'PrEP is not ready for our community, and our community is not ready for PrEP': pre-exposure prophylaxis for HIV for people who inject drugs and limits to the HIV prevention response.

@article{Guise2017PrEPIN,
  title={'PrEP is not ready for our community, and our community is not ready for PrEP': pre-exposure prophylaxis for HIV for people who inject drugs and limits to the HIV prevention response.},
  author={Andy Guise and Eliot Ross Albers and Steffanie Anne Strathdee},
  journal={Addiction},
  year={2017},
  volume={112 4},
  pages={
          572-578
        }
}
BACKGROUND AND AIMS Pre-exposure prophylaxis for HIV, or 'PrEP', is the use of antiretroviral medicines by people who are HIV-negative to protect themselves against acquiring HIV. PrEP has shown efficacy for preventing HIV acquisition. Despite the potential, many concerns have been voiced by people who inject drugs (PWID) and their organizations. There is a need to engage with these views and ensure their integration in to policy and strategy. This paper presents PWID views on PrEP to foster… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 26 times. VIEW TWEETS

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

Substance Use and Adherence to HIV Preexposure Prophylaxis for Men Who Have Sex with Men1

Emerging infectious diseases • 2018
View 5 Excerpts
Highly Influenced

Commentary: the value of PrEP for people who inject drugs

Journal of the International AIDS Society • 2016
View 3 Excerpts
Highly Influenced